Achrocidin; Acetphenetidin; Contradouleur; P-Acetophenetidide; Codempiral; P-Ethoxyacetanilide; Acetophenetin; N-(4-Ethoxyphenyl)Acetamide; Acetophenetidin; Acetamide, N-(4-Ethoxyphenyl)-; 4'-Ethoxyacetanilide; Acetophenetidine

Brief Introduction

The antipyretic effect of phenacetin is stronger than the analgesic effect. The efficacy intensity is equivalent to that of aspirin, the effect is slow and lasting, and the toxicity is low. The research shows that this product and its metabolite paracetamol have antipyretic effect. Because when phenacetin can not be converted into paracetamol with enzyme inhibitors, it can still show obvious antipyretic effect. Therefore, the antipyretic effect of thread product is not only produced by its active product paracetamol.

Choline

MSDS

CAS:62-49-7

Molecular Formula:C5H14NO+

Alias

More Information

Cholinebitartratefcc; Chlolinebitartarate; Ethanaminium, 2-Hydroxy-N,N,N-Trimethyl-; Sincalin; [3H]-Choline; Choline Base Aqueous; Cholinecation; 2-Hydroxy-N,N,N-Trimethyl-Ethanaminium; Bilineurine; Choline Ion

Brief Introduction

Organic synthetic intermediates; For biochemical research.

Methyl Nitrite

MSDS

CAS:624-91-9

Molecular Formula:CH3NO2

Alias

More Information

Methylnitrite (6Ci); Methylester Kyseliny Dusite; Nitrous Acid, Methyl Ester; Einecs 210-870-5; Nitrous Acid,Methyl Ester; Methylester Kyseliny Dusite [Czech]

Brief Introduction

It is used in organic synthesis, therapeutic drugs (vasodilators) and explosives.

Riociguat

MSDS

CAS:625115-55-1

Molecular Formula:C20H19FN8O2

Alias

More Information

Bay 63-2521; Riociguat (Jan/Inn); N-[4,6-Diamino-2-[1-[(2-Fluorophenyl)Methyl]-1H-Pyrazolo[3,4-B]Pyridin-3-Yl]-5-Pyrimidinyl]-N-Methylcarbamic Acid Methyl Ester; Adempas; Methyl N-(4,6-Diamino-2-{1-((2-Fluorophenyl)Methyl)-1H-Pyrazolo(3,4-B)Pyridin-3-Yl}Pyrimidin-5-Yl)-N-Methylcarbamate; Unii-Ru3Fe2Y4Xi; Methyl N-[4,6-Diamino-2-[1-[(2-Fluorophenyl)Methyl]Pyrazolo[3,4-B]Pyridin-3-Yl]Pyrimidin-5-Yl]-N-Methylcarbamate

Brief Introduction

Riociguat (trade name Adempas) is a novel drug (by Bayer) that is a stimulator of soluble guanylate cyclase (sGC). Clinical trials have looked at riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.

1
···
53
54
55
56
57
58
59
···
265

Inquiry (

/ 10

)

Clear All